InvestorsHub Logo
Followers 35
Posts 4675
Boards Moderated 0
Alias Born 12/14/2013

Re: Sam81 post# 62197

Friday, 10/23/2015 8:46:18 AM

Friday, October 23, 2015 8:46:18 AM

Post# of 427370
Thank You Sam


Once again, the weekly scripts shows that Vascepa is not gaining traction like it should.


Amarin Management hopefully has alternative plans, other than dilution, to keep the company afloat before the REDUCE-IT results are finally available because the revenue from Vascepa sales apparently is not going to do it.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News